No products in the cart.
Febuxostat may be effective in preventing contrast-induced acute kidney injury
1. This randomized control trial found that febuxostat has a reno-protective effect that can reduce the incidence of contrast-induced acute ...
Tag: nephrology
2 Minute Medicine Rewind March 27, 2023
The effect of changing screening practices and demographics on the incidence of gestational diabetes in British Columbia, 2005–2019 1. In ...
Hydrochlorothiazide does not impact risk of kidney-stone recurrence
1. In this randomized controlled trial, among patients with recurrent kidney stones, hydrochlorothiazide did not alter the risk of symptomatic ...
Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma
1. Disease-free survival in the placebo group was 50.7 months and was never reached in the intervention group; however, there ...
Sodium bicarbonate does not prevent declining kidney function in kidney transplant recipients
1. The mean eGFR slope was comparable among patients allocated to sodium bicarbonate and placebo over 24 months. 2. Sodium ...
Machine renal perfusion reduces delayed graft function after transplantation
1. In this randomized controlled trial, machine perfusion of the kidney reduced delayed graft function compared to therapeutic hypothermia. 2. ...
Cystatin C-based equation without race or sex improves accuracy of GFR estimation
1. In this cross-sectional study, serum cystatin C levels were similar in both Black and White patients at the same ...
Empagliflozin use is associated with slower progression of chronic kidney disease
1. Empagliflozin led to a lower risk of kidney disease progression in patients with chronic kidney disease (CKD) as compared ...
DART improves treatment decision-making for patients with chronic kidney disease
1. Patients with chronic kidney disease (CKD) who used Decision-Aid for Renal Therapy (DART) demonstrated improved decision quality compared to ...
Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease
1. Dapagliflozin reduced the risk of hospitalization in patients with chronic kidney disease (CKD) with and without type 2 diabetes ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.